EN
NEUROASPIS IN CZECH REPUBLIC

Aniva Int. reached an agreement for the launch of its brand NEUROASPIS (the first supplement with Clinical Study and World Patent for Multiple Sclerosis and related Neurodegenerative diseases) in Czech Republic through a specialized company in health care of patients with neurological disorders.

This agreement comes after the launch of Neuroaspis in Slovakia and ongoing discussions in Poland and Baltic States.

SHARE
BACK TO NEWS

Leave a Comment

Your email address will not be published. Required fields are marked *